Browsing by keyword "hepatitis C"
Now showing items 1-2 of 2
-
State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015New direct-acting antivirals have the ability to cure chronic hepatitis C virus infection, but the costs of these treatments and the number of patients that need them could bring about financial struggles for health systems. This journal article examines Medicaid reimbursement for HCV medications in the periods before and after the aforementioned direct-acting antivirals were made available. The report also analyzes the the effect of Medicaid expansion on reimbursement for direct-acting antivirals.
-
The Opioid-related Syndemic in Rural Northern New England: Findings from the DISCERNNE StudyThis presentation will discuss the risk and resource environment surrounding the syndemic of opioid use disorder, HCV and overdose in rural communities in the northern New England, and opportunities to prevent Scott County-like HIV outbreaks. These findings are from the Drug Injector Surveillance and Care Enhancement in Rural Northern New England (DISCERNNE) study.
